Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2618)
All Articles published online
|
Nov 1, 2004 (publication date) through Dec 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li GQ, Zhang HF. Mad2 and p27 expression profiles in colorectal cancer and its clinical significance. World J Gastroenterol 2004; 10(21): 3218-3220 [PMID: 15457580 DOI: 10.3748/wjg.v10.i21.3218] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i21/3218.htm |
| Number | Citing Articles |
| 1 |
Maggie K.-L. Fung, Hiu-Wing Cheung, Hing-Lok Wong, Hiu-Fung Yuen, Ming-Tat Ling, Kowk-Wah Chan, Yong-Chuan Wong, Annie L.-M. Cheung, Xianghong Wang. MAD2 expression and its significance in mitotic checkpoint control in testicular germ cell tumour. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2007; 1773(6): 821 doi: 10.1016/j.bbamcr.2007.03.014
|
| 2 |
W. Brian Dalton, Vincent W. Yang. Mitotic origins of chromosomal instability in colorectal cancer. Current Colorectal Cancer Reports 2007; 3(2): 59 doi: 10.1007/s11888-007-0001-y
|
| 3 |
Kiyoshi Takagi, Yasuhiro Miki, Yukiko Shibahara, Yasuhiro Nakamura, Akiko Ebata, Mika Watanabe, Takanori Ishida, Hironobu Sasano, Takashi Suzuki.
BUB1 Immunolocalization in Breast Carcinoma: Its Nuclear Localization as a Potent Prognostic Factor of the Patients. Hormones and Cancer 2013; 4(2): 92 doi: 10.1007/s12672-012-0130-x
|
| 4 |
Lin Li, De-Bin Xu, Xiao-Li Zhao, Tian-Yu Hao. Combination analysis of Bub1 and Mad2 expression in endometrial cancer: act as a prognostic factor in endometrial cancer. Archives of Gynecology and Obstetrics 2013; 288(1): 155 doi: 10.1007/s00404-012-2706-7
|
| 5 |
Jacek R. Wiśniewski, Pawel Ostasiewicz, Matthias Mann. High Recovery FASP Applied to the Proteomic Analysis of Microdissected Formalin Fixed Paraffin Embedded Cancer Tissues Retrieves Known Colon Cancer Markers. Journal of Proteome Research 2011; 10(7): 3040 doi: 10.1021/pr200019m
|
| 6 |
Young Hyeh Ko, Ji Hyeon Roh, Young‐Ik Son, Man Ki Chung, Jeon Yeob Jang, Hayoung Byun, Chung‐Hwan Baek, Han‐Sin Jeong. Expression of mitotic checkpoint proteins BUB1B and MAD2L1 in salivary duct carcinomas. Journal of Oral Pathology & Medicine 2010; 39(4): 349 doi: 10.1111/j.1600-0714.2009.00835.x
|
| 7 |
Yuduo Guo, Peng Huang, Weihai Ning, Hongwei Zhang, Chunjiang Yu. Identification of Core Genes and Pathways in Medulloblastoma by Integrated Bioinformatics Analysis. Journal of Molecular Neuroscience 2020; 70(11): 1702 doi: 10.1007/s12031-020-01556-1
|
| 8 |
Sudeshna Mukherjee, Sugata Manna, Debolina Pal, Pratima Mukherjee, Chinmay K. Panda. RETRACTED: Sequential loss of cell cycle checkpoint control contributes to malignant transformation of murine embryonic fibroblasts induced by 20‐methylcholanthrene. Journal of Cellular Physiology 2010; 224(1): 49 doi: 10.1002/jcp.22089
|
| 9 |
E. Burum‐Auensen, P. M. DeAngelis, A. R. Schjølberg, J. Røislien, O. Mjåland, O. P. F. Clausen. Reduced level of the spindle checkpoint protein BUB1B is associated with aneuploidy in colorectal cancers. Cell Proliferation 2008; 41(4): 645 doi: 10.1111/j.1365-2184.2008.00539.x
|
| 10 |
E. Ioachim. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. International Journal of Clinical Practice 2008; 62(11): 1736 doi: 10.1111/j.1742-1241.2006.01105.x
|
| 11 |
Keun-Yeong Jeong, Minhee Park. Poly adenosine diphosphate-ribosylation, a promising target for colorectal cancer treatment. World Journal of Gastrointestinal Oncology 2021; 13(6): 574-588 doi: 10.4251/wjgo.v13.i6.574
|
| 12 |
Caroline Rimkus, Jan Friederichs, Robert Rosenberg, Bernhard Holzmann, Jörg‐Rüdiger Siewert, Klaus‐Peter Janssen. Expression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancer. International Journal of Cancer 2007; 120(1): 207 doi: 10.1002/ijc.22155
|
| 13 |
Agoston T. Agoston, Pedram Argani, Angelo M. De Marzo, Jessica L. Hicks, William G. Nelson. Retinoblastoma Pathway Dysregulation Causes DNA Methyltransferase 1 Overexpression in Cancer via MAD2-Mediated Inhibition of the Anaphase-Promoting Complex. The American Journal of Pathology 2007; 170(5): 1585 doi: 10.2353/ajpath.2007.060779
|
| 14 |
MASANARI MORISHITA, TOSHIYUKI SUMI, YUSUKE NAKANO, MASATOMO TERAMAE, TAKESHI FUKUDA, HIROYUKI NOBEYAMA, HIROYUKI YOSHIDA, YOSHINARI MATSUMOTO, TOMOYO YASUI, OSAMU ISHIKO. Expression of mitotic-arrest deficiency 2 predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer. Experimental and Therapeutic Medicine 2012; 3(2): 341 doi: 10.3892/etm.2011.407
|
| 15 |
Nicholas FS Watson, Lindy G Durrant, John H Scholefield, Zahra Madjd, Duncan Scrimgeour, Ian Spendlove, Ian O Ellis, Poulam M Patel. Cytoplasmic expression of p27<sup>kip1</sup> is associated with a favourable prognosis in colorectal cancer patients. World Journal of Gastroenterology 2006; 12(39): 6299-6304 doi: 10.3748/wjg.v12.i39.6299
|
| 16 |
Li Wang, Fang Yin, Yulei Du, Wenqi Du, Bei Chen, Yongguo Zhang, Kaichun Wu, Jie Ding, Jie Liu, Daiming Fan. MAD2 as a Key Component of Mitotic Checkpoint. American Journal of Clinical Pathology 2009; 131(6): 793 doi: 10.1309/AJCPBMHHD0HFCY8W
|
| 17 |
Heng Wang, Wei Wang, Zhen Wang, Xu Li. Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1291859
|
| 18 |
Beth AA Weaver, Don W Cleveland. Does aneuploidy cause cancer?. Current Opinion in Cell Biology 2006; 18(6): 658 doi: 10.1016/j.ceb.2006.10.002
|
| 19 |
Espen Burum-Auensen, Paula M. De Angelis, Aasa R. Schjølberg, Katherine L. Kravik, Marit Aure, Ole Petter F. Clausen. Subcellular Localization of the Spindle Proteins Aurora A, Mad2, and BUBR1 Assessed by Immunohistochemistry. Journal of Histochemistry & Cytochemistry 2007; 55(5): 477 doi: 10.1369/jhc.6A7077.2007
|
| 20 |
YUSUKE NAKANO, TOSHIYUKI SUMI, MASANARI MORISHITA, TAKESHI FUKUDA, HIROYUKI NOBEYAMA, HIROYUKI YOSHIDA, YOSHINARI MATSUMOTO, TOMOYO YASUI, OSAMU ISHIKO. Mitotic arrest deficiency 2 induces carcinogenesis in mucinous ovarian tumors. Oncology Letters 2012; 3(2): 281 doi: 10.3892/ol.2011.483
|
| 21 |
Alejandro López-Saavedra, Luis A. Herrera. The role of alternative mRNA splicing in chromosome instability. Mutation Research/Reviews in Mutation Research 2010; 705(3): 246 doi: 10.1016/j.mrrev.2010.09.002
|
| 22 |
Mafalda Pinto, Maria J. Soares, Nuno Cerveira, Rui Henrique, Franclim R. Ribeiro, Jorge Oliveira, Carmen Jerónimo, Manuel R. Teixeira. Expression changes of the MAD mitotic checkpoint gene family in renal cell carcinomas characterized by numerical chromosome changes. Virchows Archiv 2007; 450(4): 379 doi: 10.1007/s00428-007-0386-7
|
| 23 |
Tara Byrne, Helen G. Coleman, Janine A. Cooper, W. Glenn McCluggage, Amanda McCann, Fiona Furlong. The association between MAD2 and prognosis in cancer: a systematic review and meta-analyses. Oncotarget 2017; 8(60): 102223 doi: 10.18632/oncotarget.18414
|
| 24 |
Giorgia Simonetti, Samantha Bruno, Antonella Padella, Elena Tenti, Giovanni Martinelli. Aneuploidy: Cancer strength or vulnerability?. International Journal of Cancer 2019; 144(1): 8 doi: 10.1002/ijc.31718
|
| 25 |
Rohini Samadarsi, Linus Augustin, Chandan Kumar, Debjani Dutta. In-silico and in-vitro studies on the efficacy of mangiferin against colorectal cancer. BMC Chemistry 2022; 16(1) doi: 10.1186/s13065-022-00835-9
|
| 26 |
Vânia Diogo, Joana Teixeira, Patrícia M.A. Silva, Hassan Bousbaa. Spindle Assembly Checkpoint as a Potential Target in Colorectal Cancer: Current Status and Future Perspectives. Clinical Colorectal Cancer 2017; 16(1): 1 doi: 10.1016/j.clcc.2016.06.006
|
| 27 |
Acacia F. Dishman, Francis C. Peterson, Brian F. Volkman. Specific binding‐induced modulation of the XCL1 metamorphic equilibrium. Biopolymers 2021; 112(10) doi: 10.1002/bip.23402
|
| 28 |
L Yang, S Feng, Y Yang. Identification of transcription factors (TFs) and targets involved in the cholangiocarcinoma (CCA) by integrated analysis. Cancer Gene Therapy 2016; 23(12): 439 doi: 10.1038/cgt.2016.64
|